Delivery Order SPE2DB24D1201-SPE2DB25FJDZH
Award Date 8/20/25
Potential Completion Date 8/21/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $12,499.08 to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 ml pen injections) on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. FORTEO is an FDA-approved pharmaceutical treatment for osteoporosis and bone-related conditions, commonly utilized within military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,192.61 to supply FORTEO (teriparatide) 560 micrograms per 2.24 milliliter pen injections. This competitively awarded, firm fixed price delivery order was issued on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. FORTEO is a prescription medication used to treat osteoporosis,...
- The Defense Logistics Agency awarded a $6,492.02 delivery order to AmerisourceBergen Drug Corp for FORTEO (forteoide) 560 mcg/2.24 mL pen injections on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order to be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. FORTEO is a prescription injectable medication commonly used in the treatment of osteoporosis...
- The Defense Logistics Agency awarded a delivery order valued at $47,923.50 to AmerisourceBergen Drug Corp for the supply of FORTEO (560 mcg/2.24 mL pen injection), a pharmaceutical treatment for osteoporosis. The contract, awarded on April 21, 2025, with an ultimate completion date of April 22, 2025, was issued without a set-aside designation under a firm fixed price arrangement. Performance of this delivery order will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of FORTEO (fortified with 560 mcg/2.24 mL pen injections). The contract, which became effective on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Conshohocken facility....
- The Defense Logistics Agency awarded a $12,869.67 delivery order to AmerisourceBergen Drug Corp for FORTEO (560 mcg/2.24 mL pen injections), a brand-name pharmaceutical product used in osteoporosis treatment. The contract is a firm fixed-price delivery order with an ultimate completion date of May 19, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,220.43 for FORTEO 560 mcg/2.24 mL pen injections on June 3, 2025, with completion targeted for June 4, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio. The product will be performed at the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for FORTEO 560 MCG/2.24 ML pen injections on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed price contract, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FORTEO (Fortified Growth Factor) 560 MCG/2.24 ML pen injections on June 18, 2025, with completion targeted for June 20, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement to support federal medical supply needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters...
- The Defense Logistics Agency has awarded a $15,608.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of FORTEO (forteoide) 560 mcg/2.24 mL pen injections. The contract, awarded on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract...